Suven Formulation Development Centre

  • Pharmaceutical Dosage Form Development for Global Markets Including Analytical & Regulatory Services
  • Equipped with State-of-the Art Infrastructure in 110,000 Sft. Facilities for Product Development, Technology Development, Analytical, cGMP Compliant Pilot / Small scale Manufacturing
  • Qualified and Experienced Team

Generic Product Development

  • Pre-Formulation Studies
  • Formulation Development
  • Process Development
  • Exhibit / Submission / Pivotal Batches
  • Co-ordination with CROs for BE Studies*
  • Technology Transfer

New Chemical Entities (NCE) Formulations

  • Product Development (Preclinical & Clinical)
  • Clinical Trials Material (CTM):
  • Multi-Product Manufacturing for Ph-I, II, III (Including Placebo)
  • Multi-Product Packaging for Ph-I, II, III

New / Novel Drug Delivery Systems

  • Modified Release
  • Technology Platforms
  • Alternate Routes of Delivery

Analytical Services

  • Analytical Method Development
  • Analytical Method Validation
  • Impurity Profiling
  • Stability Testing
  • Microbiological Testing

Regulatory Services

  • Pre & Post Submission
  • Pre & Post Approval

Parenteral Iron Formulations

First Line Treatment for Iron Deficiency Anemia in Non-Dialysis, Hemo Dialysis and Peritoneal Dialysis Dependent Patients

Iron Sucrose Injection USP
Sodium Ferric Gluconate Complex in Sucrose Injection

Niche Formulation Portfolio

Treatment of Choice for Head Lice

Malathion Lotion USP - 0.5%
* Customer exclusivity for some markets.
  1. Formulation Development Centre View PDF

Suven Life Sciences Limited

Serene Chambers,
Road-5, Avenue 7,
Banjara Hills,
Hyderabad-500034, Telangana,
INDIA.

Phone:
+91 (40) 2354 1142
Fax:
+91 (40) 2354 1152

1100 Cornwall Road,
Monmouth Junction,
NJ-08852, USA.

Phone:
+1 (732) 274 0037
Fax:
+1 (732) 274 0501

www.suven.com, enquiry@suven.com, info@suven.com